- Design
- Scoping review with narrative synthesis
- Population
- 48 articles on adults taking a beta-blocker and an SSRI, 1990–2025
- Primary outcome
- Any reported adverse event from the combination
- Effect
- Bradycardia most reported (11 articles), mainly metoprolol or propranolol with fluoxetine, paroxetine or sertraline
This scoping review searched for any adverse event attributed to taking a beta-blocker and an SSRI together, covering 1990 to 2025. It included 48 articles, mostly interventional studies and case reports.
Bradycardia was the commonest reported problem, largely in case reports of metoprolol with fluoxetine, paroxetine or sertraline, and propranolol with fluoxetine. Blood pressure changes, including hypotension, appeared in half of the studies that looked. There were also case reports of self-poisoning with the combination.
The mechanism most authors proposed is pharmacokinetic: fluoxetine and paroxetine are strong CYP2D6 inhibitors, and metoprolol and propranolol depend partly on CYP2D6 for clearance. Inhibiting it can raise beta-blocker levels several-fold. Atenolol and bisoprolol rely less on this pathway.
The combination is common, for example propranolol for the physical symptoms of anxiety alongside an SSRI. This review gathers signals; it does not estimate how often harm occurs.
- Check heart rate and blood pressure after starting fluoxetine or paroxetine in a patient on metoprolol or propranolol.
- Consider a beta-blocker less dependent on CYP2D6, such as atenolol or bisoprolol, when an interacting SSRI is needed.
- Prefer an SSRI with weaker CYP2D6 inhibition, such as citalopram or escitalopram, when the beta-blocker must stay.
- Ask about dizziness, fatigue and syncope at follow-up in patients on both drugs.
- Assess overdose risk when prescribing this combination to patients with depression.
Why it matters
A common anxiety-and-depression pairing carries a predictable interaction that is easy to design out.
Don't overread it
Most evidence is case reports; this does not measure how often the combination causes harm.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for clinical pharmacology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free